Akebia Therapeutics Inc (NASDAQ:AKBA)

0.3321
Delayed Data
As of May 20
 -0.0158 / -4.57%
Today’s Change
0.31
Today|||52-Week Range
4.33
-85.31%
Year-to-Date

Today’s Trading

Previous close0.35
Today’s open0.36
Day’s range0.31 - 0.37
Volume11,523,171
Average volume (3 months)8,648,116
Market cap$60.1M
Data as of 4:04pm ET, 05/20/2022

Growth & Valuation

Earnings growth (last year)+38.46%
Earnings growth (this year)+51.43%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)-27.68%
P/E ratioNM
Price/Sales1.76
Price/Book0.76

Competitors

 Today’s
change
Today’s
% change
BLRXBioLine RX Ltd-0.02-1.93%
ORTXOrchard Therapeutics...-0.01-2.04%
ADMPAdamis Pharmaceutica...-0.03-7.73%
--Herantis Pharma Oyj0.000.00%
Data as of 4:04pm ET, 05/20/2022

Financials

Next reporting dateAugust 10, 2022
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$213.6M
Annual profit (last year)-$282.8M
Net profit margin-132.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts